Logo image of ECDA

ECD AUTOMOTIVE DESIGN INC (ECDA) Stock Fundamental Analysis

NASDAQ:ECDA - Nasdaq - US27877D1046 - Common Stock - Currency: USD

0.375  -0.04 (-8.98%)

Premarket: 0.3402 -0.03 (-9.28%)

Fundamental Rating

1

Overall ECDA gets a fundamental rating of 1 out of 10. We evaluated ECDA against 41 industry peers in the Automobiles industry. ECDA has a bad profitability rating. Also its financial health evaluation is rather negative. ECDA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ECDA had negative earnings in the past year.
In the past year ECDA has reported a negative cash flow from operations.
ECDA Yearly Net Income VS EBIT VS OCF VS FCFECDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -2M -4M

1.2 Ratios

ECDA's Return On Assets of -15.68% is in line compared to the rest of the industry. ECDA outperforms 48.78% of its industry peers.
Industry RankSector Rank
ROA -15.68%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECDA Yearly ROA, ROE, ROICECDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 100 150

1.3 Margins

ECDA has a better Gross Margin (30.48%) than 87.80% of its industry peers.
ECDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ECDA Yearly Profit, Operating, Gross MarginsECDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 10 -10 20

0

2. Health

2.1 Basic Checks

ECDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ECDA remains at a similar level compared to 1 year ago.
ECDA has a worse debt/assets ratio than last year.
ECDA Yearly Shares OutstandingECDA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M
ECDA Yearly Total Debt VS Total AssetsECDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that ECDA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.92, ECDA is in line with its industry, outperforming 58.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC11.66%
ECDA Yearly LT Debt VS Equity VS FCFECDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 0.87 indicates that ECDA may have some problems paying its short term obligations.
ECDA has a Current ratio of 0.87. This is in the lower half of the industry: ECDA underperforms 68.29% of its industry peers.
A Quick Ratio of 0.33 indicates that ECDA may have some problems paying its short term obligations.
With a Quick ratio value of 0.33, ECDA is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.33
ECDA Yearly Current Assets VS Current LiabilitesECDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M 20M

4

3. Growth

3.1 Past

The earnings per share for ECDA have decreased by -9.68% in the last year.
ECDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.52%.
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-680%
Revenue 1Y (TTM)22.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%80.57%

3.2 Future

The Earnings Per Share is expected to grow by 62.27% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 39.65% on average over the next years. This is a very strong growth
EPS Next Y-650%
EPS Next 2Y-144.95%
EPS Next 3Y106.06%
EPS Next 5Y62.27%
Revenue Next Year53.61%
Revenue Next 2Y39.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ECDA Yearly Revenue VS EstimatesECDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M 40M
ECDA Yearly EPS VS EstimatesECDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

ECDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ECDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECDA Price Earnings VS Forward Price EarningsECDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECDA Per share dataECDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as ECDA's earnings are expected to grow with 106.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-144.95%
EPS Next 3Y106.06%

0

5. Dividend

5.1 Amount

No dividends for ECDA!.
Industry RankSector Rank
Dividend Yield N/A

ECD AUTOMOTIVE DESIGN INC

NASDAQ:ECDA (4/22/2025, 8:00:03 PM)

Premarket: 0.3402 -0.03 (-9.28%)

0.375

-0.04 (-8.98%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)05-02 2025-05-02
Inst Owners1.63%
Inst Owner Change0%
Ins Owners71.23%
Ins Owner Change0%
Market Cap13.27M
Analysts82.86
Price Target5.1 (1260%)
Short Float %0.75%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.5%
PT rev (3m)-37.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-57.14%
EPS NY rev (3m)-57.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.09
BVpS-0.34
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.68%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.48%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 201.94%
Cap/Sales 1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.33
Altman-Z 0.92
F-Score3
WACC11.66%
ROIC/WACCN/A
Cap/Depr(3y)398.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-680%
EPS Next Y-650%
EPS Next 2Y-144.95%
EPS Next 3Y106.06%
EPS Next 5Y62.27%
Revenue 1Y (TTM)22.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%80.57%
Revenue Next Year53.61%
Revenue Next 2Y39.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-682.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-435.18%
OCF growth 3YN/A
OCF growth 5YN/A